Autolus Therapeutics plc American Depositary Share (AUTL)

Price$1.53

Value ScoreC

Growth ScoreA

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)9.78%

Price vs S&P 500 (4W)-0.38%

VGM Score62.37

Market Capitalization$441.82M

All Metrics

Book Value / Share (Quarterly)$1.30

P/TBV (Annual)3.31x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)128.01%

Price vs S&P 500 (YTD)-27.61%

Gross Margin (TTM)-11.19%

Net Profit Margin (TTM)-311.98%

EPS (TTM)$-1.09

10-Day Avg Trading Volume1.44M

EPS Excl Extra (TTM)$-1.09

Revenue Growth (5Y)112.99%

EPS (Annual)$-1.08

ROI (Annual)-64.13%

Gross Margin (Annual)-26.10%

Net Profit Margin (5Y Avg)-4654.61%

Cash / Share (Quarterly)$1.71

Revenue Growth QoQ (YoY)191.89%

ROA (Last FY)-48.81%

Revenue Growth TTM (YoY)927.90%

EBITD / Share (TTM)$-0.96

ROE (5Y Avg)-99.04%

Operating Margin (TTM)-285.91%

Cash Flow / Share (Annual)$-0.30

P/B Ratio4.06x

P/B Ratio (Quarterly)3.37x

Net Income / Employee (Annual)$-381,300

EV / Revenue (TTM)6.35x

Net Interest Coverage (TTM)-17.39x

ROA (TTM)-46.25%

EPS Incl Extra (Annual)$-1.08

Current Ratio (Annual)5.94x

Quick Ratio (Quarterly)5.03x

3-Month Avg Trading Volume1.60M

52-Week Price Return-20.57%

Revenue / Employee (TTM)$122,800

Tangible BV / Share (Quarterly)$1.25

P/S Ratio (Annual)5.86x

Asset Turnover (Annual)0.13x

52-Week High$2.70

Operating Margin (5Y Avg)-4610.29%

EPS Excl Extra (Annual)$-1.08

CapEx CAGR (5Y)13.07%

Tangible BV CAGR (5Y)-9.06%

26-Week Price Return21.17%

Quick Ratio (Annual)5.19x

13-Week Price Return1.84%

Total Debt / Equity (Annual)1.52x

Current Ratio (Quarterly)5.80x

Enterprise Value$588.16M

Revenue / Share Growth (5Y)53.36%

Asset Turnover (TTM)0.15x

Revenue / Employee (Annual)$100,000

Pretax Margin (Annual)-378.78%

Cash / Share (Annual)$3.53

3-Month Return Std Dev71.88%

Net Income / Employee (TTM)$-383,200

ROE (Last FY)-161.42%

Net Interest Coverage (Annual)-5.41x

EPS Basic Excl Extra (Annual)$-1.08

Receivables Turnover (TTM)4.11x

Total Debt / Equity (Quarterly)2.55x

EPS Incl Extra (TTM)$-1.09

Receivables Turnover (Annual)5.49x

ROI (TTM)-59.20%

P/S Ratio (TTM)4.77x

Pretax Margin (5Y Avg)-4933.00%

Revenue / Share (Annual)$0.28

Price vs S&P 500 (52W)-47.62%

Year-to-Date Return-16.58%

5-Day Price Return-11.23%

EPS Normalized (Annual)$-1.08

ROA (5Y Avg)-39.58%

Net Profit Margin (Annual)-381.40%

Month-to-Date Return-11.23%

Cash Flow / Share (TTM)$-0.97

EBITD / Share (Annual)$-0.99

Operating Margin (Annual)-358.87%

LT Debt / Equity (Annual)1.52x

ROI (5Y Avg)-53.19%

LT Debt / Equity (Quarterly)2.55x

EPS Basic Excl Extra (TTM)$-1.09

P/TBV (Quarterly)4.09x

P/B Ratio (Annual)2.94x

Inventory Turnover (TTM)4.30x

Pretax Margin (TTM)-311.32%

Price vs S&P 500 (13W)-8.66%

Beta2.09x

Revenue / Share (TTM)$0.35

ROE (TTM)-128.59%

52-Week Low$1.18

vGradeC

gGradeA

mGradeC

vgmGradeB

Show chart for

Earnings Surprise History

Q1 26-0.27est. -0.26

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.28

4.29

Industry Peers — Biological Products(178)

Symbol	Value Score	Growth Score	Momentum Score	Price
AUTLAutolus Therapeutics plc American Depositary Share	C	A	C	$1.53
AMGNAmgen Inc	C	C	C	$349.58
GILDGilead Sciences Inc	C	B	C	$129.16
ARGXargenx SE American Depositary Shares	D	A	B	$891.32
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$149.23
BIIBBiogen Inc. Common Stock	B	D	B	$195.34
BNTXBioNTech SE American Depositary Share	C	C	D	$88.08
MRNAModerna, Inc. Common Stock	C	B	B	$47.44
NBIXNeurocrine Biosciences Inc	C	B	B	$163.88
EXELExelixis Inc	C	B	B	$52.70
KRYSKrystal Biotech, Inc. Common Stock	D	B	A	$301.00

About

Autolus Therapeutics develops next-generation programmed T-cell therapies for cancer treatment. The biopharmaceutical company's clinical-stage pipeline is anchored by Obe-cel and includes several additional programs (AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7, and AUTO8) at varying developmental stages.